|
Secondary prevention
Citations 21-26 of 26 total displayed.
|
Past content
(since Aug 1999):
|
- Atherosclerosis and Lipoproteins
Antioxidant Supplements Block the Response of HDL to Simvastatin-Niacin Therapy in Patients With Coronary Artery Disease and Low HDL
- Marian C. Cheung, Xue-Qiao Zhao, Alan Chait, John J. Albers, and B. Greg Brown
Arterioscler Thromb Vasc Biol 2001;21:1320-1326, doi:10.1161/hq0801.095151
[Abstract]
[Full text]
- Atherosclerosis and Lipoproteins
In Vivo Anti-Inflammatory Effect of Statins Is Mediated by Nonsterol Mevalonate Products
- Luisa Diomede, Diego Albani, Marcello Sottocorno, Maria Benedetta Donati, Marco Bianchi, Paolo Fruscella, and Mario Salmona
Arterioscler Thromb Vasc Biol 2001;21:1327-1332, doi:10.1161/hq0801.094222
[Abstract]
[Full text]
- Atherosclerosis and Lipoproteins
Effect of Oral Postmenopausal Hormone Replacement on Progression of Atherosclerosis : A Randomized, Controlled Trial
- Peter Angerer, Stefan Störk, Wolfgang Kothny, Philip Schmitt, and Clemens von Schacky
Arterioscler Thromb Vasc Biol 2001;21:262-268
[Abstract]
[Full text]
- Atherosclerosis and Lipoproteins
Apolipoprotein Concentrations During Treatment and Recurrent Coronary Artery Disease Events
- Jeanine E. Roeters van Lennep, H. Tineke Westerveld, Henk W. O. Roeters van Lennep, Aelko H. Zwinderman, D. Willem Erkelens, and Ernst E. van der Wall
Arterioscler Thromb Vasc Biol 2000;20:2408-2413
[Abstract]
[Full text]
- Editorials
On the Association of Elevated tPA/PAI-1 Complex and von Willebrand Factor With Recurrent Myocardial Infarction
- Henri Bounameaux and Egbert K. O. Kruithof
Arterioscler Thromb Vasc Biol 2000;20:1857-1859
[Full text]
- Brief Reviews
Coronary Heart Disease: Reducing the Risk : The Scientific Background to Primary and Secondary Prevention of Coronary Heart DiseaseA Worldwide View
- Gerd Assmann, Paul Cullen, Fabrizio Jossa, Barry Lewis, and Mario Mancini
Arterioscler Thromb Vasc Biol 1999;19:1819-1824
[Full text]
|
|
